Evidence map›Paper›PMID 26512199›Full record

ReviewBioinformatics and biology insights2015

Machine Learning Methods for Predicting HLA-Peptide Binding Activity.

Heng Luo, Hao Ye, Hui Wen Ng, Leming Shi, Weida Tong, Donna L Mendrick, Huixiao Hong

Abstract readReview
In one paragraph

Review in Bioinformatics and biology insights, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Unlocking the potential of AI: Machine learning and deep learning models for predicting carcinogenicity of chemicals.Journal of environmental science and health. Part C, Toxicology and carcinogenesis · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Machine learning and deep learning for brain tumor MRI image segmentation.Experimental biology and medicine (Maywood, N.J.) · 2023
    Review
  9. Article
  10. Review of machine learning and deep learning models for toxicity prediction.Experimental biology and medicine (Maywood, N.J.) · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. The pockets guide to HLA class I molecules.Biochemical Society transactions · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Heng LuoNational Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA. ; University of Arkansas at Little Rock/University of Arkansas for Medical Sciences Bioinformatics Graduate Program, Little Rock, AR, USA.
Hao YeNational Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.
Hui Wen NgNational Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.
Leming ShiCenter for Pharmacogenomics, School of Pharmacy, Fudan University, Shanghai, China.
Weida TongNational Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.
Donna L MendrickNational Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.
Huixiao HongNational Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.

Funding

Understanding Hesitant AdoptersP20GM103429 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Lawrence E Cornett, JERRY WARE · 2012 to 2026
$60.9M
VIRULENCE MECHANISMS IN ESCHERICHIA COLIP20RR016460 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI HENSLEY, LORI · 2001 to 2011
$33.1M
NCRR NIH HHS P20 RR016460NIGMS NIH HHS P20 GM103429
6 · The paper itself

Abstract

As major histocompatibility complexes in humans, the human leukocyte antigens (HLAs) have important functions to present antigen peptides onto T-cell receptors for immunological recognition and responses. Interpreting and predicting HLA-peptide binding are important to study T-cell epitopes, immune reactions, and the mechanisms of adverse drug reactions. We review different types of machine learning methods and tools that have been used for HLA-peptide binding prediction. We also summarize the descriptors based on which the HLA-peptide binding prediction models have been constructed and discuss the limitation and challenges of the current methods. Lastly, we give a future perspective on the HLA-peptide binding prediction method based on network analysis.

Indexed as

bindingHLAmachine learningMHCpeptideprediction

Identifiers

PMID26512199
PMCPMC4603527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.